Epizyme (EPZM) Misses Q3 EPS by 16c

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.64), $0.16 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $13.18 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• XP Inc eyes US banking license as next business step